Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase

被引:44
作者
Moore, ML
McKissic, EL
Brown, CC
Wilkinson, JE
Spindler, KR
机构
[1] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[5] Univ Georgia, Coll Vet Med, Dept Pathol, Athens, GA 30602 USA
[6] Univ Georgia, Franklin Coll Arts & Sci, Dept Genet, Athens, GA 30602 USA
关键词
D O I
10.1128/JVI.78.11.5584-5590.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Mouse adenovirus type 1 (MAV-1) infection of B-cell-deficient and Bruton's tyrosine kinase (Btk)-deficient mice resulted in fatal disseminated disease resembling human adenovirus infections in immunocompromised patients. Mice lacking B cells or Btk were highly susceptible to acute MAV-1 infection, in contrast to controls and mice lacking T cells. To our knowledge, this is the first demonstration that mice with an X-linked immunodeficiency phenotype (Btk deficient) are susceptible to virus-induced disease. Mice lacking B cells or Btk on a C57BL/6 background succumbed with encephalomyelitis, hepatitis, and lymphoid necrosis. Mice lacking B cells on a BALB/c background succumbed with enteritis and hepatitis. Survival of acute MAV-1 infection correlated with early T-cell-independent neutralizing antibody and T-cell-independent antiviral immunoglobulin M. Treatment of MAV-1-infected Btk(-/-) mice 4 to 9 days postinfection with antiserum harvested 6 to 9 days postinfection from MAV-1-infected Btk(+/+) mice was therapeutic. Our findings implicate a critical role for B-cell function in preventing disseminated MAV-1 infection, particularly production of early T-cell-independent antiviral immunoglobulin M.
引用
收藏
页码:5584 / 5590
页数:7
相关论文
共 47 条
[1]   Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection [J].
Balkow, S ;
Kersten, A ;
Tran, TTT ;
Stehle, T ;
Grosse, P ;
Museteanu, C ;
Utermöhlen, O ;
Pircher, H ;
von Weizsäcker, F ;
Wallich, R ;
Müllbacher, A ;
Simon, MM .
JOURNAL OF VIROLOGY, 2001, 75 (18) :8781-8791
[2]   B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection [J].
Baumgarth, N ;
Herman, OC ;
Jager, GC ;
Brown, LE ;
Herzenberg, LA ;
Chen, JZ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (02) :271-280
[3]  
Baumgarth N, 2000, IMMUNOL REV, V176, P171
[4]  
Berke Z, 1998, IN VIVO, V12, P143
[5]  
BLANKE C, 1995, AM J MED, V99, P326, DOI 10.1016/S0002-9343(99)80169-7
[6]   ACUTE ADENOVIRUS HEPATITIS IN LIVER-TRANSPLANT RECIPIENTS [J].
CAMES, B ;
RAHIER, J ;
BURTOMBOY, G ;
DEGOYET, JD ;
REDING, R ;
LAMY, M ;
OTTE, JB ;
SOKAL, EM .
JOURNAL OF PEDIATRICS, 1992, 120 (01) :33-37
[7]  
CARMICHAEL GP, 1979, AM J CLIN PATHOL, V71, P352
[8]  
Carrigan Donald R., 1997, American Journal of Medicine, V102, P71, DOI 10.1016/S0002-9343(97)00015-6
[9]  
CAUTHEN AN, 1999, METH MOLEC MED, V21, P85
[10]   Mouse adenovirus type-1 replication is restricted to vascular endothelium in the CNS of susceptible strains of mice [J].
Charles, PC ;
Guida, JD ;
Brosnan, CF ;
Horwitz, MS .
VIROLOGY, 1998, 245 (02) :216-228